Your browser doesn't support javascript.
loading
Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer.
Foldi, Julia; Tsagianni, Anastasia; Salganik, Max; Schnabel, Catherine A; Brufsky, Adam; van Londen, G J; Pusztai, Lajos; Sanft, Tara.
  • Foldi J; Section of Medical Oncology, Yale School of Medicine, New Haven, CT, 06510, USA. Foldij@upmc.edu.
  • Tsagianni A; Division of Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA. Foldij@upmc.edu.
  • Salganik M; Division of Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.
  • Schnabel CA; Biotheranostics Inc, A Hologic Company, San Diego, CA, 92121, USA.
  • Brufsky A; Biotheranostics Inc, A Hologic Company, San Diego, CA, 92121, USA.
  • van Londen GJ; Division of Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.
  • Pusztai L; Division of Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.
  • Sanft T; Section of Medical Oncology, Yale School of Medicine, New Haven, CT, 06510, USA.
BMC Cancer ; 23(1): 606, 2023 Jun 30.
Article en En | MEDLINE | ID: mdl-37391697
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Interfaces Cerebro-Computador Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Interfaces Cerebro-Computador Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article